147 related articles for article (PubMed ID: 2627754)
1. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism.
Wehling M; Kuhnle U; Daumer C; Armanini D
Clin Endocrinol (Oxf); 1989 Nov; 31(5):597-605. PubMed ID: 2627754
[TBL] [Abstract][Full Text] [Related]
2. [Receptor-effector relations in the effect of adosterone on mononuclear leukocytes: validation and application to various water and electrolyte imbalances in humans].
Wehling M
Klin Wochenschr; 1989 Jan; 67(1):1-5. PubMed ID: 2537910
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leucocytes from patients with pseudohypoaldosteronism.
Wehling M; Kuhnle U; Witzgall H; Weber PC; Armanini D
Clin Endocrinol (Oxf); 1988 Jan; 28(1):67-74. PubMed ID: 3168302
[TBL] [Abstract][Full Text] [Related]
4. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects.
Kuhnle U; Nielsen MD; Tietze HU; Schroeter CH; Schlamp D; Bosson D; Knorr D; Armanini D
J Clin Endocrinol Metab; 1990 Mar; 70(3):638-41. PubMed ID: 2137831
[TBL] [Abstract][Full Text] [Related]
5. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities.
Armanini D; Wehling M; Da Dalt L; Zennaro M; Scali U; Keller U; Pratesi C; Mantero F; Kuhnle U
J Steroid Biochem Mol Biol; 1991; 40(1-3):363-5. PubMed ID: 1659876
[TBL] [Abstract][Full Text] [Related]
6. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
Kuhnle U; Hinkel GK; Hubl W; Reichelt T
Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
[TBL] [Abstract][Full Text] [Related]
7. Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension.
Wehling M; Kuhls S; Kuhnle U; Theisen K
Klin Wochenschr; 1990 Jan; 68(2):71-6. PubMed ID: 2157089
[TBL] [Abstract][Full Text] [Related]
8. Familial pseudohypoaldosteronism.
Popow C; Pollak A; Herkner K; Scheibenreiter S; Swoboda W
Acta Paediatr Scand; 1988 Jan; 77(1):136-41. PubMed ID: 2967023
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro.
Wehling M; Käsmayr J; Theisen K
Cell Calcium; 1990 Oct; 11(9):565-71. PubMed ID: 2285925
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorescence of mineralocorticoid receptors in peripheral lymphocytes: presence of receptor-like activity in patients with the autosomal dominant form of pseudohypoaldosteronism, and its absence in the recessive form.
Kuhnle U; Keller U; Armanini D; Funder J; Krozowski Z
J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):267-73. PubMed ID: 7826888
[TBL] [Abstract][Full Text] [Related]
11. High affinity aldosterone binding to plasma membrane rich fractions from mononuclear leukocytes: is there a membrane receptor for mineralocorticoids?
Wehling M; Christ M; Theisen K
Biochem Biophys Res Commun; 1991 Dec; 181(3):1306-12. PubMed ID: 1662496
[TBL] [Abstract][Full Text] [Related]
12. The early mineralocorticoid effector mechanism, the sodium-proton exchanger, is sensitized in lymphocytes from patients with Cushing's syndrome.
Wehling M; Käsmayr J; Christ M; Sippell W; Theisen K; Müller OA
Clin Endocrinol (Oxf); 1992 Sep; 37(3):260-5. PubMed ID: 1330384
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes.
Wehling M; Armanini D; Strasser T; Weber PC
Am J Physiol; 1987 Apr; 252(4 Pt 1):E505-8. PubMed ID: 2952017
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid effector mechanism in human mononuclear leukocytes.
Armanini D; Wehling M; Weber PC
J Steroid Biochem; 1987; 27(4-6):967-70. PubMed ID: 2826915
[TBL] [Abstract][Full Text] [Related]
15. Impaired rapid mineralocorticoid action on free intracellular calcium in pseudohypoaldosteronism.
Gamarra F; Simic-Schleicher G; Huber RM; Ulsenheimer A; Scriba PC; Kuhnle U; Wehling M
J Clin Endocrinol Metab; 1997 Mar; 82(3):831-4. PubMed ID: 9062491
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone-receptor deficiency in pseudohypoaldosteronism.
Armanini D; Kuhnle U; Strasser T; Dorr H; Butenandt I; Weber PC; Stockigt JR; Pearce P; Funder JW
N Engl J Med; 1985 Nov; 313(19):1178-81. PubMed ID: 2932642
[TBL] [Abstract][Full Text] [Related]
17. Familial pseudohypoaldosteronism: a review on the heterogeneity of the syndrome.
Kuhnle U; Hinkel GK; Akkurt HI; Krozowski Z
Steroids; 1995 Jan; 60(1):157-60. PubMed ID: 7792804
[TBL] [Abstract][Full Text] [Related]
18. A partial form of pseudohypoaldosteronism type I without renal sodium wasting.
Ballauff A; Wendel U; Kupke I; Kuhnle U
J Pediatr Endocrinol; 1994; 7(1):57-60. PubMed ID: 8186826
[TBL] [Abstract][Full Text] [Related]
19. Contribution to problems of pseudohypoaldosteronism type I in children.
Bayer M; Kutílek S
Med Hypotheses; 1993 Sep; 41(3):277-8. PubMed ID: 8259090
[TBL] [Abstract][Full Text] [Related]
20. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?
Wehling M; Käsmayr J; Theisen K
Am J Physiol; 1991 May; 260(5 Pt 1):E719-26. PubMed ID: 1852112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
